| Business Summary | | ImmuCell
Corporation
is
a
biotechnology
company
dedicated
to
producing
proprietary
products
that
improve
animal
health
and
productivity
in
the
dairy
and
beef
industry.
In
addition
to
operating
an
animal
health
business,
the
Company
has
obtained
U.K.
regulatory
approval
to
sell
CRYPTO-SCAN,
a
product
that
is
used
in
the
detection
of
CRYPTOSPORIDIUM
in
drinking
water.
Further,
the
Company
has
demonstrated
preliminary
efficacy
in
an
open
label,
Phase
I/II
efficacy
study
of
DIFFGAM,
an
alternative
to
antibiotics
in
the
treatment
and/or
prevention
of
CLOSTRIDIUM
DIFFICILE-associated
diarrhea
in
humans. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | ImmuCell
Corporation
is
a
biotechnology
company
engaged
in
the
development
of
animal
health
products
to
expand
its
commercialized
line
of
products
for
use
by
dairy
and
beef
producers.
For
the
three
months
ended
3/31/01,
total
revenues
increased
3%
to
$1.5
million.
Net
income
decreased
49%
to
$116
thousand.
Revenues
reflect
increased
sales
of
the
First
Defense
Detector.
Net
income
reflects
the
inclusion
of
a
$77
thousand
income
tax
expense. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
1,837;
after
tax
earnings
were
105. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Michael Brigham, 40 Pres,
CEO, Treasurer, Sec., Director | $103K | $25.9K | Joseph Crabb, Ph.D., 46 VP,
CSO, Director | 103K | 4.5K | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|